Our partner Dr. Katy Ritzmann reports on the Technology Hotspot Israel and the different legal structures for investors in Germany and Israel in an interview with VentureCapital Magazin.
Press contact
presse@gsk.de
+49 30 203907-7763
Dr. Katy Ritzmann
Partner*
+49 30 203907-422
katy.ritzmann@gsk.de